Immunowake

Birmingham, United States

Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies.

$20.0M raised

May 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Immunowake raised?

Immunowake has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in May 2022.

Who are Immunowake's investors?

Immunowake's investors include Lapam Capital, South China Venture Capital, HEDA Ventures, Hyfinity Investments.

Where is Immunowake headquartered?

Immunowake is headquartered in Birmingham, United States.

What does Immunowake do?

Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies.

What stage is Immunowake at?

Immunowake is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 15, 2022.

MLA

"Immunowake — Funding & Investors." VCBacked, May 15, 2022, https://www.vcbacked.co/company/immunowake. Accessed July 2, 2026.

APA

VCBacked. (2022). Immunowake — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/immunowake

Wikipedia (cite web)

{{cite web |title=Immunowake — Funding & Investors |url=https://www.vcbacked.co/company/immunowake |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 15, 2022.